Mertk promotes early microglial-mediated synaptic engulfment in Alzheimer's disease

Yifan Wu1,2, Yuanteng Fan3, Shisan Bao4

  • 1School of Basic Medical Sciences, Taikang Medical School, Wuhan University, 185 Donghu Road, Wuhan, 430071, China.

Theranostics
|December 8, 2025
PubMed

Insights

Microglia excessively prune synapses in early Alzheimer's disease (AD). Upregulated Mertk drives this synaptic loss, suggesting Mertk as a therapeutic target for AD.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Synaptic deficits precede hallmark pathologies in Alzheimer's disease (AD).
  • Microglia, the brain's immune cells, can excessively prune synapses, contributing to neuronal dysfunction.
  • The specific role of the microglial phagocytic receptor Mertk in early AD-related synaptic loss is not well understood.

Purpose of the Study:

  • To investigate the role of Mertk in microglial-mediated synaptic loss during the early stages of Alzheimer's disease.
  • To elucidate the molecular mechanisms by which microglia contribute to synaptic deficits in AD.

Main Methods:

  • Single-cell RNA sequencing (scRNA-seq) was employed to analyze microglial transcriptional profiles in early-stage AD mouse models.
  • Mertk-mediated synaptic engulfment was assessed through in vivo and in vitro experimental approaches.

Main Results:

  • Phagocytic microglia with elevated Mertk expression were identified in early AD mouse models.
  • Dysregulated microglial synaptic pruning led to hippocampal synaptic loss and memory impairments in AD mice.
  • Mertk knockout or inhibition ameliorated excessive microglial synapse elimination.
  • Amyloid-beta oligomers (Aβo) induced PPARγ, which promoted Mertk transcription and subsequent synaptic phagocytosis by microglia.

Conclusions:

  • PPARγ-regulated Mertk-mediated microglial engulfment of synapses contributes to early synaptic loss in Alzheimer's disease.
  • Microglial Mertk represents a promising therapeutic target for mitigating early synaptic dysfunction in AD.